Efficacy of lenvatinib versus sorafenib in the primary treatment of advanced hepatocellular carcinoma: A meta-analysis.
Vikash JaiswalMaha HameedSidra NazPoulami RoyNovonil DebJanta UkraniGautham Varun Krishna MohanAmira M TahaHelen HuangVikash KumarBhavyakumar VachhaniAbdelrahman M AttiaSupti D NathMostafa A SolimnDattatreya MukherjeePublished in: JGH open : an open access journal of gastroenterology and hepatology (2023)
Our study shows that lenvatinib is superior to sorafenib regarding OS and PFS in patients with advanced HCC.
Keyphrases